Sebastian Palmqvist, MD, PhD
Sebastian Palmqvist, MD, PhD
Associate professor at Lund University, Consultant Neurologist at Skåne University Hospital (Sweden)
Verifierad e-postadress på - Startsida
Citeras av
Citeras av
Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography
S Palmqvist, H Zetterberg, K Blennow, S Vestberg, U Andreasson, ...
JAMA neurology 71 (10), 1282-1289, 2014
Plasma β-amyloid in Alzheimer’s disease and vascular disease
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...
Scientific reports 6 (1), 1-11, 2016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
S Janelidze, H Zetterberg, N Mattsson, S Palmqvist, H Vanderstichele, ...
Annals of clinical and translational neurology 3 (3), 154-165, 2016
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1-13, 2017
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
S Palmqvist, N Mattsson, O Hansson, ADN Initiative
Brain 139 (4), 1226-36, 2016
Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder
O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ...
Neurology 88 (10), 930-937, 2017
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, L Minthon, ...
Neurology 85 (14), 1240-1249, 2015
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
N Mattsson, PS Insel, S Palmqvist, E Portelius, H Zetterberg, M Weiner, ...
EMBO molecular medicine 8 (10), 1184-1196, 2016
18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
N Mattsson, M Schöll, O Strandberg, R Smith, S Palmqvist, PS Insel, ...
EMBO molecular medicine 9 (9), 1212-1223, 2017
Discriminative accuracy of [18F] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ...
Jama 320 (11), 1151-1162, 2018
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests
S Palmqvist, O Hansson, L Minthon, E Londos
International journal of geriatric psychiatry 24 (12), 1405-1412, 2009
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer’s disease in mild cognitive impairment: six-year follow-up study
S Palmqvist, J Hertze, L Minthon, C Wattmo, H Zetterberg, K Blennow, ...
PLoS One 7 (6), e38639, 2012
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
R Lautner, S Palmqvist, N Mattsson, U Andreasson, A Wallin, E Pålsson, ...
JAMA psychiatry 71 (10), 1183-1191, 2014
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease
M Schöll, R Ossenkoppele, O Strandberg, S Palmqvist, ...
Brain 140 (9), 2286-2294, 2017
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
S Janelidze, N Mattsson, E Stomrud, O Lindberg, S Palmqvist, ...
Neurology 91 (9), e867-e877, 2018
The Montreal Cognitive Assessment: normative data from a large Swedish population-based cohort
E Borland, K Nägga, PM Nilsson, L Minthon, ED Nilsson, S Palmqvist
Journal of Alzheimer's Disease 59 (3), 893-901, 2017
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
O Voevodskaya, PC Sundgren, O Strandberg, H Zetterberg, L Minthon, ...
Neurology 86 (19), 1754-1761, 2016
Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
N Mattsson, R Smith, O Strandberg, S Palmqvist, M Schöll, PS Insel, ...
Neurology 90 (5), e388-e395, 2018
Performance of fully automated plasma assays as screening tests for Alzheimer disease–related β-amyloid status
S Palmqvist, S Janelidze, E Stomrud, H Zetterberg, J Karl, K Zink, T Bittner, ...
JAMA neurology 76 (9), 1060-1069, 2019
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20